Better Education on Glomerulonephritis: Improving Knowledge of IgA Nephropathy

To participate in this activity, please:

Nephrology experts Jai Radhakrishnan, MD, and Dana Rizk, MD, delve into the complex disease of immunoglobulin A nephropathy (IgAN), addressing unmet treatment needs and novel frontiers of therapy. They discuss IgAN as a chronic disease, reviewing its pathophysiologic basis, morbidity and mortality including significant reductions in health-related quality of life, existing treatment options, and evolving new targeted therapies. The experts review treatment strategies and highlight case studies to depict key components of management and share their experience in conceptualizing this disease state with an eye towards improving long-term health outcomes.

This program is also available as a podcast. You may download it here:

Course Credit:

1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour


Opens: 2022-07-31
Closes: 2023-09-30

Target Audience:

This activity was developed for nephrologists, pediatricians, general internists, surgeons who specialize in organ transplants, and other healthcare professionals who may be involved in the diagnosis and treatment of patients with IgAN.

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

    Presenting Faculty

  • Jai Radhakrishnan, MD

    Professor of Medicine
    Clinical Chief, Nephrology Division
    Columbia University Medical Center
    New York, New York

  • Dana Rizk, MD

    Professor of Medicine
    Division of Nephrology
    Medical Director
    Clinical Trials Administration Office
    University of Alabama at Birmingham
    Birmingham, Alabama